Inhibition of CK2 using CX-4945 resulted in decreased phospho-STAT3 levels in multiple myeloma and mantle cell lymphoma cells as well as suppression of STAT3 target genes (Cyclin D1, IL-6) [41]. Here, STAT3 is linked to plasma cell myeloma.